Inappropriate Ordering, Prescribing or Dispensing of Medications to Treat COVID-19


This joint statement was issued by the AMA, APhA, and ASHP to address the inappropriate use of medications to treat COVID-19. This statement reminds physicians, pharmacists, and health systems of their role as stewards of health care resources during this pandemic.


It goes on to discourage prophylactic use of medications such as chloroquine, hydroxychloroquine, and azithromycin to prevent COVID-19 and cautions that no treatment has been approved by the FDA for COVID-19. Through this statement, the organizations support direct prescribing of medications for a specific medical purpose.

Read Statement

Need More COVID-19 Resources?

Visit Toolkit

Content Related to this Article

05.18.2021
Article

2021 Funds For Safety Grant Recipients

LHA Trust Funds is proud to announce the recipients of the 2021 Funds for Safety Grant program.

Learn More

03.18.2021
Article

OSHA Adopts New Covid-19 National Emphasis Program

Learn More

01.18.2021
Article

How to Store the COVID-19 Vaccine Securely

Learn More